Does TAVABOROLE Cause Application site haemorrhage? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Application site haemorrhage have been filed in association with TAVABOROLE (Tavaborole). This represents 1.4% of all adverse event reports for TAVABOROLE.
10
Reports of Application site haemorrhage with TAVABOROLE
1.4%
of all TAVABOROLE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Application site haemorrhage From TAVABOROLE?
Of the 10 reports.
Is Application site haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAVABOROLE. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does TAVABOROLE Cause?
Drug ineffective (129)
Application site erythema (71)
Application site exfoliation (56)
Application site pain (54)
Application site irritation (40)
Nail discolouration (38)
Drug administered at inappropriate site (37)
Erythema (36)
Pruritus (36)
Skin exfoliation (30)
What Other Drugs Cause Application site haemorrhage?
PEGFILGRASTIM (1,394)
MINOXIDIL (78)
BUPRENORPHINE (68)
ESTRADIOL (64)
DOCOSANOL (62)
BECAPLERMIN (60)
INGENOL MEBUTATE (50)
FENTANYL (47)
EVOLOCUMAB (45)
NICOTINE (37)
Which TAVABOROLE Alternatives Have Lower Application site haemorrhage Risk?
TAVABOROLE vs TAXOL
TAVABOROLE vs TAXOTERE
TAVABOROLE vs TAZAROTENE
TAVABOROLE vs TAZEMETOSTAT
TAVABOROLE vs TAZEMETOSTAT HYDROBROMIDE